CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
3.59 / 10
Netural
Capital flow is robust with a fund flow score of 7.18/10, indicating strong inflow momentum. Small-cap trends are positive, while larger block flows are negative, hinting at short-term buying pressure offset by institutional selling. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one analyst, yet the historical win rate is 0%, underscoring skepticism. The combination of positive fund flow and bullish analyst stance contrasts with weak technicals and a neutral overall score.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-03-12
InstitutionCraig-Hallum
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for CSBR?
- CSBR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.59/10 (Netural).
